Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Furrer

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
HIV Medicine|April 16, 2008
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyM Wolbers, H C Bucher, H Furrer, et al.
Journal of Internal Medicine|February 20, 2007
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapyJ A C Sterne, M May, H C Bucher, et al.
Swiss Medical Weekly|October 20, 2001
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapyM Rossi, M Flepp, A Telenti, et al.
AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.
The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.
HIV Medicine|November 26, 2002
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort StudyH C Bucher, M Bichsel, P Taffé, et al.
HIV Medicine|October 15, 2013
A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infectionA Mocroft, L Ryom, P Reiss, et al.
Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.
HIV Medicine|March 20, 2014
The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovirJ Young, Q Wang, C A Fux, et al.
Lancet (London, England)|March 27, 1999
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyB Ledergerber, M Egger, M Opravil, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
HIV Medicine|April 16, 2008
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyM Wolbers, H C Bucher, H Furrer, et al.
Journal of Internal Medicine|February 20, 2007
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapyJ A C Sterne, M May, H C Bucher, et al.
Swiss Medical Weekly|October 20, 2001
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapyM Rossi, M Flepp, A Telenti, et al.
AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.
The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.
HIV Medicine|November 26, 2002
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort StudyH C Bucher, M Bichsel, P Taffé, et al.
HIV Medicine|October 15, 2013
A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infectionA Mocroft, L Ryom, P Reiss, et al.
Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.
HIV Medicine|March 20, 2014
The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovirJ Young, Q Wang, C A Fux, et al.
Lancet (London, England)|March 27, 1999
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyB Ledergerber, M Egger, M Opravil, et al.
Pageof 10